11ß-HSD1 and Metabolic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Metabolic SyndromeImpaired Glucose Tolerance
Interventions
DRUG

rosiglitazone

89 mg BID for 8 weeks, orally

Trial Locations (1)

12200

Charite, Campus Benjamin Franklin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT00370305 - 11ß-HSD1 and Metabolic Syndrome | Biotech Hunter | Biotech Hunter